LeMaitre Vascular: Poised for best day in 9-1/2 yrs on Q4 beat, strong forecast

LeMaitre Vascular

20/02/2019 15:36

** Medical device maker's shares  LMAT.O  up 22.9 pct at
$30.86 in early trading after Q4 results beat estimates
    ** LMAT is the 2nd-biggest gainer among U.S. stocks, and is
on pace for its best day in 9-1/2 years  
    ** Says quarter was helped by a surge its sales rep, and its
2 recent acquisitions  urn:newsml:reuters.com:*:nGNX8xdp7j
    ** Also forecasts 2019 revenue largely above estimates
    ** Canaccord Genuity says Q4 results, 2019 guide look
"oustanding", but since much of upside came from recent deals it
is not expected to generate operating leverage near-term
    ** Brokeraqe lowers PT to $23 from $26, which implies a
downside of ~8 pct to stock's last close; median PT $26
    ** Including session gains, LMAT has risen 31 pct this year

 (Reporting by Amy Caren Daniel in Bengaluru)
 ((Reuters Messaging:
Amy.CarenDaniel.thomsonreuters.com@reuters.net))